The FDA has increased the number of medication approvals exponentially over the past 10 years. In 2020, 53 new drugs and biologics were approved as compared to 48 in 2019. Of the ones approved last year, 40% were first in class, and 58% received indications to manage rare diseases.

This CE addresses approximately 35 of the new medications approved in 2020 that the average pharmacist may not have had time to review and keep track of as they entered the market. This presentation will address this gap and focus on medications used primarily in the Ambulatory Care and Community practice settings. The information is centered not only on how the medications work but also includes clinical trial summaries that led to their approval by the FDA which will be discussed in relation to current EBM guidelines and treatment algorithms.

At the conclusion of this continuing education activity, the participant will be able to:

1. Identify the new pharmaceutical agents available for clinical practice
2. Outline the use of new pharmaceutical agents in clinical practice
3. Explain the benefits, risks, and alternatives of new pharmaceutical agents

At the conclusion of this continuing education activity, the participant will be able to:

1. Identify the new pharmaceutical agents available for clinical practice
2. Outline the use of new pharmaceutical agents in clinical practice
3. Explain the benefits, risks, and alternatives of new pharmaceutical agents

At the conclusion of this continuing education activity, the participant will be able to:

1. Identify the new pharmaceutical agents available for clinical practice
2. Outline the use of new pharmaceutical agents in clinical practice
3. Explain the benefits, risks, and alternatives of new pharmaceutical agents

AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-868287.

AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268.
Start Date: 07/14/2022
Expiration Date: 07/14/2025

Timothy R. Brown, PharmD, FASHP is the Director of Interprofessional Education at the College of Pharmacy of the University of Georgia.

This activity was developed by AchieveCE free of any commercial support. Timothy R. Brown, PharmD, FASHP, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose. Jaimini Patel, RPh and Pete Kreckel, RPh, planners for this educational event, also have no relevant financial relationship(s) with ineligible companies to disclose.

  Level 2. Basic Application of Skills and Concepts